CITIGROUP INC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$43,362,617
+73.8%
1,644,392
+13.4%
0.03%
+106.2%
Q2 2023$24,943,716
-4.2%
1,450,216
-7.6%
0.02%
-11.1%
Q1 2023$26,026,372
+146.6%
1,569,745
+13.3%
0.02%
+125.0%
Q4 2022$10,553,159
-33.6%
1,384,929
-13.3%
0.01%
-27.3%
Q3 2022$15,887,000
+18.7%
1,598,261
+8.4%
0.01%
+10.0%
Q2 2022$13,387,000
+16.6%
1,474,402
+30.4%
0.01%
+42.9%
Q1 2022$11,480,000
-43.2%
1,131,040
-6.7%
0.01%
-36.4%
Q4 2021$20,222,000
-9.6%
1,212,338
+154.1%
0.01%
-15.4%
Q3 2021$22,359,000
-41.7%
477,043
-24.2%
0.01%
-43.5%
Q2 2021$38,366,000
+3.2%
629,360
+4.3%
0.02%
-4.2%
Q1 2021$37,169,000
-3.3%
603,400
+11.7%
0.02%
+4.3%
Q4 2020$38,424,000
+41.0%
540,353
-25.6%
0.02%
+27.8%
Q3 2020$27,255,000
+3.1%
726,408
-10.4%
0.02%
-14.3%
Q2 2020$26,441,000
+679.1%
810,813
+592.8%
0.02%
+600.0%
Q1 2020$3,394,000
+288.3%
117,038
+368.8%
0.00%
+200.0%
Q4 2019$874,000
+4061.9%
24,963
+2386.4%
0.00%
Q3 2019$21,0001,0040.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders